Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial
Options
Publisher DOI
Date of Publication
2008
Publication Type
Article
Language(s)
en
Contributor(s)
Califf, RM | |
Boolell, M | |
Haffner, SM | |
Bethel, MA | |
McMurray, J | |
Duggal, A | |
Holman, RR | |
Study Group |
Series
American Heart Journal
Publisher
Elsevier
ISSN
0002-8703
Access(Rights)
metadata.only